News

The EXTEND trial provided 5-year follow-up for 10 patients with advanced retinitis pigmentosa, who had previously received MCO-010 during a phase 1/2a trial

Data suggests that EYP-1901 can reduce the number of injections and treatment burden for patients

Adverum Biotechnologies is known for its therapeutic candidate Ixo-vec, in development for the treatment of wet age-related macular degeneration (AMD)

Both business moves further align Topcon with a long-term strategy for promoting data-driven predictive healthcare

The professor from Wills Eye Hospital in Philadelphia, Pennsylvania, explained why it's time to retire the term "sterile" when addressing culture-negative endophthalmitis

SPVN20 is a gene-agnostic, intravitreal AAV-based gene therapy that targets dormant cones to restore vision, according to SparingVision

A mutation-agnostic gene therapy approach offers new possibilities for patients, especially those with inherited retinal diseases

The satellite of the US-based University of Miami Health System will offer a “full spectrum of ophthalmic services” in the United Arab Emirates

A recently-updated textbook details major developments in therapeutic and cosmetic keratopigmentation, including superficial and intrastromal techniques

Providers are rethinking their spaces and systems to streamline care, reduce waste, and improve patient, staff and physician satisfaction

While the FDA requests additional evidence of efficacy for the low-dose atropine eye drop in the US, the formulation has already gained European Commission approval as Ryjunea for slowing paediatric myopia progression.

Joel Schuman, MD, explore the latest advancements in glaucoma laser treatments, including innovative techniques like DSLT and the benefits of selective laser trabeculoplasty

Sahar Bedrood, MD, discusses her experience with the LEOS endoscopic laser system's enhanced precision and efficiency, promising improved patient outcomes in glaucoma surgery.

The novel therapeutic for keratoconus does not require corneal epithelium removal and is slated to launch commercially in early 2026.

A new study reveals a promising drug reduces vision loss in Stargardt disease, showing significant safety and efficacy over 2 years.

Continued research shows that earlier treatment significantly enhances tissue preservation in patients with geographic atrophy, emphasizing the importance of timely intervention.

A study shows enhanced safety and efficacy in epi-on cross-linking for keratoconus, utilizing oxygen-rich boost goggles during treatment.

Dr Khanani shared his first-time results talk during an AAO specialty day

At the 2025 Academy of American Ophthalmology meeting, Prof Stalmans described safety and efficacy benefits of disposable non-contact vitrectomy lenses

Dr Borkar, a vitreoretinal surgeon at Duke University, spoke to the Eye Care Network about her American Academy of Ophthalmology (AAO) presentation

The investigators noted that this report is the first about subretinal drusenoid deposits in Black and Hispanic patients with age-related macular degeneration

Jean-Francois Korobelnik, MD, shares highlights from the PULSAR extension study showcasing aflibercept 8 mg and its ability to promote fluid resolution

The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD

The full range of vision lens debuted at the 2025 ESCRS meeting in Copenhagen

Patients with proliferative diabetic retinopathy, central retinal vein occlusion and branch retinal vein occlusion experienced fluctuating retinal perfusion, investigators reported

Dr Chhablani said "having multiple approaches to the same problem" is key for reaching the maximum number of patients with age-related macular degeneration

The agenda includes subspecialty days, evening events and partner programmes from practice management organisations